Why the study?
Does simultaneous aortic valve replacement and coronary bypass grafting impact long-term survival compared to aortic valve replacement alone in patients without coronary artery disease?
Does simultaneous aortic valve replacement and coronary bypass grafting impact long-term survival compared to aortic valve replacement alone in patients without coronary artery disease?
Simultaneous AVR and CABG is associated with a 65% actuarial survival at 42 months, which is lower than the 76% survival seen in AVR patients without severe coronary disease, with the highest mortality observed in patients with aortic regurgitation.
Answers are grounded in this paper and cite their sources.
Combined AVR+CABG was associated with lower survival; leaves open whether concomitant grafting affects outcomes in patients with coronary disease.
From 1967 through 1973, 80 consecutive patients underwent simultaneous aortic valve replacement (AVR) and coronary bypass grafting. Fourteen (18%) experienced no angina pectoris and had no history or electrocardiographic evidence of coronary atherosclerosis. Seven of these 14 had severe multiple vessel disease. All operations were performed under normothermic conditions without coronary perfusion. Seven patients (9%) died during operation. Intra-operative myocardial infarction was documented in eight (10%). After a mean follow-up of 35 months, overall mortality was highest in aortic regurgitation patients [seven of 13 (54%)] compared to aortic stenosis [17 of 54 (31%)] (P less than 0.07), and mixed pathology [1 of 13 (8%)]. Thirty-one of 34 (91%) grafts in 25 patients were patent an average of 12 months postoperatively. After 42 months a 65% actuarial survival was found in the combined AVR and graft(s) series versus a 76% survival in 300 AVR patients proven by angiography not to have severe coronary atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Loop et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: